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INTRODUCTION 
  
  
LIPID BASED DRUG DELIVERY SYSTEMS  
 
Drugs which are poorly water solubility are made well suitable for lipid-based 
formulation. Water insoluble and weakly basic drugs require special care in the design and 
development of lipid based formulation. These drugs administered in the solubilized form in 
the lipid vehicle may come out of the formulation due to solubilisation in the gastric fluid and 
may precipitate in the intestinal fluid on gastric emptying. The bioavailability of this system 
would depend on how rapidly the precipitates can be resolubilized by the formulation.(Sanjay 
Singh et al., 2009). 
The percentage of new chemical entities synthesized with low aqueous solubility and high 
therapeutic efficacy is growing, this presents a major challenge for the drug delivery. To 
overcome the above challenge different methods were developed for the enhancement of 
bioavailability.  
Lipid based formulations are more effective delivery system for oral route and improve 
bioavailability because of its proven safety and efficacy. Lipid Formulation Classification 
System was established by Pouton et al., It aims to enable in vivo studies for interpreting and 
for the identification of the most appropriate formulations for specific drugs, their 
physiochemical properties are taken into consideration. (Maulik Patel et al., 2011) 
 
NANO STRUCTURED LIPID CARRIER (NLC) 
 
A Nano structured lipid carrier (NLC) are the new generation of lipid nanoparticles, attracting 
major attention as novel colloidal drug carriers which is composed of physiological lipid 
materials suitable for topical, dermal, and transdermal administrations. To illustrate, several 
problems have been reported with the conventional topical preparations, e.g., low uptake due 
to the barrier function of the stratum corneum and unwanted absorption to the systemic 
circulation. Several systems which are provided in literature review can deliver active 
pharmaceutical ingredients across the skin presenting advantages in systemic treatment with 
minimal side effects, the absence of first-pass metabolism, and in topical treatment allowing 
targeting specific skin appendages. NLC has been developed to overcome the drawbacks 
dealing with Solid Lipid Nanoparticles (SLN). SLN is produced by replacing the oil of an 
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o/w emulsion by a solid lipid or a blend of solid lipid, i.e., the lipid particle matrix being solid 
at both room and body temperature. NLC consist mixture of solid lipid (long chain) and 
liquid lipid (short chain), preferably in a ratio of 70:30 up to a ratio of 99.9:0.1. The resulting 
matrix of the lipid particle shows a melting point depression compared to the original solid 
lipid, however, the matrix remains solid at body temperature. Some limitation of the SLN 
system regarding drug expulsion during storage, reduced particle concentration, reduced drug 
loading, these limitations were solved by formulating lipid particles with controlled 
nanostructure known as NLC. For some number of drugs, the solubility of liquid lipid is 
higher than that of solid lipid, which enhances drug-loading, NLC possess numerous features 
that are advantageous for the topical route of application. NLC are composed of physiological 
and biodegradable lipids that show low toxicity. The small size ensures a close contact to the 
stratum corneum and can increase the amount of drug penetrated into the skin. Due to the 
occlusive properties of lipid nanoparticles, an increased skin hydration effect is observed. 
Further these lipid nanoparticles are able to enhance the chemical stability of compounds 
sensitive to light, oxidation and hydrolysis. (shailesh patwekar et al.,2014) 
 
 
ADVANTAGES OF NLCs 
 
 Their small size and relatively narrow size distribution permits site-specific drug 
delivery. 
 Controlled and Sustained release of active drug can be achieved. 
 The incorporated drug is protected from the onslaughts of biochemical degradation. 
 High drug payload. 
 Incorporation of lipophilic and hydrophilic drugs feasible. 
 Can be sterilized by autoclave or gamma radiation. 
 Can be lyophilizes and spray dried. 
 Do not generate any toxic metabolites. 
 Relatively cheap and stable. 
 Ease of industrial scale production by hot dispersion technique. 
 Surface modification can be easily performed.  
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SOLID LIPID NANOPARTICLES (SLNs): 
 
SLNs are particulate system with particle diameters ranging 50-1000nm. They are derived 
from oil-in-water emulsions, by replacing the liquid oil by a solid lipid. Particle size of SLN 
is in submicron range, ranging from 40 to 1000 nm. They have several advantages that the 
lipid matrix is generally made from physiologically well-tolerated lipid components, which 
decreases the toxicity. They have a stability of around 3 years and can easily be manufactured 
at industrial scales. SLNs, lipid micro particles and lipospheres have been used as alternative 
carriers for therapeutic peptides, proteins and antigens. Formulation as SLNs confers 
improved protein stability, avoids proteolysis, as well as providing sustained release of the 
incorporated molecules. Well-known peptides such as cyclosporine A, insulin, calcitonin and 
somatostatin have been incorporated into solid lipid particles. (Alka Lohani, Anurag Verma 
et al., 2014). 
 
SLN PRODUCTION METHODS  
 
There are two basic methods of SLN production: high pressure homogenization (HPH) and 
microemulsion technique. Also, attempts have been made to obtain those compounds using 
less expensive and complicated methods, such as ultrasound technique (US) and solvent cast 
method. Unfortunately, those methods have a number of disadvantages. (Elwira Lanson et 
al.,2011) The basic methods of obtaining solid lipid nanoparticles are outlined below. 
 
High Pressure Homogenization (HPH) 
 
HPH has proved to be an effective and reliable method of SLN production. Homogenizers of 
various sizes are available on the market for relatively favourable prices and HPH has been 
used in the production of nano-emulsions for a number of years. Contrary to other technique, 
HPH usually does not pose any difficulties for large-scale production. High-pressure 
homogenizers force the liquid through very thin orifices (a few microns in diameter) under 
the pressure of 100-2000 bar. On very short distances, the liquid reaches very high velocity of 
over 1000 km/h. High turbulence and shear disintegrate the particles to submicron sizes. The 
typical lipid content is 5÷10% and poses no difficulty for the homogenizer. Lipid nano-
dispersion has been achieved with lipid concentration as high as 40%. HPH is further divided 
into hot and cold high pressure homogenization. In both methods the preparatory stage 
involves the introduction of active substance into the lipids through dissolution or dispersion 
of those substances in liquefied lipid mass.  
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Hot homogenization technique: 
Hot homogenization is conducted at temperatures higher than lipid melting point and can thus 
be considered homogenization in emulsion. Pre-emulsion of the active substance, melted 
lipid and water phase of the emulsifier is obtained in high speed mixer. The quality of pre-
emulsions largely determines the quality of the end product. The desirable particle sizes are 
within a few micrometres. Hot homogenization of the pre-emulsion is conducted at 
temperature higher than lipid melting point. In general, the higher the temperature, the 
smaller the particle size, caused by viscosity reduction in the internal phase. However, too 
high temperature may cause the active substance and the carrier to decompose. The 
homogenization stage can be repeated a number of times. It should be noted that 
homogenization under increased pressure causes the emulsion temperature to rise by approx. 
10° for every 500 bar. In most cases 3 to 5 homogenization cycles under 500-1,500 bar are 
sufficient. The increase of homogenization pressure or the number of cycles often results in 
the increase in particle size due to coalescence which is the product of high kinetic energy of 
particles. The basis product of hot homogenization is nanoemulsion in liquid state. Solid 
particles are obtained by cooling the sample to room temperature or lower. Due to small 
particle size and the presence of emulsifiers the crystallization of lipids can take very long 
(up to a few months).  
 
Cold homogenization technique: 
 
In the cold homogenization method, the lipid microparticles are obtained by melting and 
subsequent cooling of drug containing lipid followed by crushing, grounding and that is 
diffused in cold surfactant to obtain a cold pre-suspension of micronized lipid particles. This 
suspension is then passes through a high pressure homogenizer at room temperature by 
applying 5–10 cycles at 1500 bar. This method is most suitable for hydrophilic drugs with 
low solubility (surfactants are added to improve solubility). This technique shortens melting 
process of lipid and hence it is useful for thermo-sensitive and thermo-labile drugs. 
 
Cold homogenization has been developed in order to overcome the three fundamental 
problems of hot homogenization:          
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 Decomposition of the active substance, caused by high temperature 
 Decomposition of the active substance in the water phase during homogenization 
 Complexity of the crystallization stage of the nanoemulsion, leading to multiple 
modifications. 
 
 
Fig 1: Schematic procedure of homogenization techniques for SLN production 
 
 
Microemulsion technique 
 
In order to obtain micro emulsion with lipids in solid state at room temperature, the process 
temperature must be higher than lipid melting point. Lipids (e.g. fatty acids and/or 
triglycerides) are melted and the mixture of water, emulsifiers and co-emulsifiers is heated to 
the temperature of the lipids and blended under mild conditions. If the procedure runs 
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correctly, we will obtain transparent, thermodynamically stable complex. The hot 
microemulsion is then dispersed in chilled water (2÷3°C) by smooth mechanical stirring, 
which ensures that the small particle size results from precipitation and not the mechanical 
stirring. The volume ratio of hot microemulsion to cold water should be from 1:25 to 1:50. 
The most popular emulsifiers are polysorbate 20, polysorbate 60 and soy lecithin. The most 
frequently used co-emulsifiers are usually alcohols, e.g. butanol. Technically, the 
precipitation of lipid particles in water is equivalent to diluting the complex, which leads to 
decrease in solid substance content in SLN dispersion. Due to diluting stage the achievable 
lipid content is lower than in formulations obtained through HPH. (Elwira Lanson et 
al.,2011). 
 
 
 
 
Fig 2: Schematic diagram showing the structures formed during the production of SLN 
by microemulsion technique 
 
 
NUTRACEUTICALS 
Nutraceuticals are food products that are beneficial to the health as well as helping in 
the prevention and treatment of disease. Few nutraceuticals are being used as pharmaceuticals 
and a number of others are being used by the general public as self-medication. Such 
products may range from dietary supplements to genetically engineered foods, herbal 
products and processed foods.( Swati Chaturvedi et al., 2011) 
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Nutraceuticals have received considerable interest because of their presumed safety 
and potential nutritional and therapeutic effects”. The term arises from the words 
"Nutraceutical" "Nutrition" and "Pharmaceutical". It was coined in 1989 by Dr Stephen 
DeFelice, Chairman of the Foundation for Innovation in Medicine. “Nutraceutical” is a 
marketing term developed for nutritional supplement that is sold with the intent to treat or 
prevent disease and thus hasno regulatory definition. Hence a “nutraceutical” is any 
substance that may be considered a food or part of a food and provides medical or health 
benefits, encompassing, prevention and treatment of diseases.  About 2000 years ago, 
Hippocrates correctly emphasized “Let food be your medicine and medicine your food".(A 
Rajasekaran et al.,2008) 
 
ADVANTAGES OF ESSENTIAL OIL IN COSMETICEUTICAL FORMULATION 
 
1. Enhancing the dermato-cosmetic properties and preservation, as well as the marketing 
image of the product. 
2. At relatively high concentration in cosmetics it provide skin benefit. 
 
NUTRICOSMETIC 
Nutricosmetic means ingredients added may not only act on skin, hair, and nails but also have more 
systemic effect that resulting in the improved health and fitness. The important mechanism of this 
nutricosmetics is it mainly focusing on the carotenoid and phenolic ingredients to enhance the health 
and fitness by combining nutricosmetical and cosmeceutical applications, that is combined oral and 
topical applications and also combining nutricosmetical and physiotherapeutical interventions, that is 
combined oral and exercise or massage applications (Jan taeymans et al.,2014). 
 
TETRAHYDRO CURCUMIN 
Tetrahydro curcumin (THC), one of the major metabolites of curcumin, which has same 
physiological and pharmacological properties as that of curcumin. THC is insoluble in water 
and soluble in alcohol, acetone and glacial acetic acid. The pharmacological effect of THC is 
limited due to its low aqueous solubility. In addition, a relative short gastric emptying time 
can result in an incomplete release of THC from the dosage form at the site of absorption 
which cause diminished efficacy of the administered dose. 
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The regular curcuminoids once ingested reach to intestine, where they need to pass through 
the absorption barrier to enter the biological system. Further the reductase system at the 
cellular level then converts the curcumin to tetra hydocurcumin. Tetrahydro curcumin is an 
active metabolite of the curcumin as investigation in its activity reveals. 
 
THC has been identified in the intestinal and hepatic cytosol from humans and rats. 
The reduction of curcumin to THC was proposed to occur via a reductase enzyme in the 
cytosolic compartment either in intestine or hepatic cells. THC has also been demonstrated 
that it has anti-cancer and anti-angiogenic effect and prevents type II diabetes. It was also 
proved that it is more effective than curcumin in preventing azoxymethane induced colon 
carcinogenesis (P Murugan et al., 2007). 
 
THC is categorized as BCS class IV drugs owing to its poor aqueous solubility and poor GI 
absorption. 
 
In the present context, development of nutricosmetics with natural preservation system will 
be beneficial for the broad application and development of nutricosmetics. The present 
investigation is focused on the  development and optimization of natural preservation system 
and development of nutricosmetic loaded with nano lipid carrier with nutraceutical.    
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OBJECTIVE 
In Recent years, Bacterial contamination changes physical and chemical properties of 
cosmetics usually resulting in phase separation, discoloration and release of odours etc. Rich 
composition of modern cosmetics in combination with aqueous formulation and direct 
exposure to bacterial skin flora make them an ideal environment for microbial growth. 
Taking into consideration the high risk of contamination and therefore a risk for consumers 
health, the use of preservatives is a necessity.  
 
Preservation systems prevent and control the growth of microorganisms from contamination 
during manufacturing, storage or consumer use. Completely preservative-free and microbial 
stable cosmetics are made by sterile production and appropriate packaging. However, 
satisfactory results can be achieved only for some formulations and are under certain 
restrictions: 
 
Preservative systems usually include various combinations of chemical biocides that operate 
on a broad spectrum of bacteria and fungi. They offer a high antimicrobial efficacy and 
therefore prolong the shelf-life of products, however, many of them can cause adverse 
reactions to skin.  
 
A promising strategy to overcome these problems involves the development of suitable drug 
carrier systems. Nowadays, essential oils are the subject of intensive scientific research and 
also attract attention of cosmetic and pharmaceutical industries due to their potential 
therapeutic benefits as well as natural preservation effect. A new promising field of 
application of essential oils as natural preservatives in cosmetics or feed additives in human 
or animal food or as plant protection products has been studied. It is estimated that more than 
3000 essential oils are of commercial importance and used in flavor and cosmetic industries. 
The microbial safety of cosmetics has been always of special interest for industries, as 
microbial spoilage can lead to product degradation and cause a risk to consumers’ health. 
It has become more and more evident that the development of new drugs alone is not 
sufficient to ensure progress in drug therapy. Exciting experimental data obtained in vitro are 
very often followed by disappointing results in vivo due to poor drug solubility, poor 
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absorption, rapid metabolism and elimination, high fluctuation of plasma levels due to 
unpredictable bioavailability after peroral administration.  
The carriers should permit a controlled and localized release of the drug according to the 
specific needs of the therapy which determines the in vivo fate of the drug. The size of the 
carrier depends on the desired route of administration and ranges from few nanometres to the 
micrometer. 
 Nano structured lipid carriers are proved to be suitable carriers with various 
advantages like (i) controlled release of the drug (ii) increased drug stability (iii) high drug 
loading (iv) no bio toxicity of the carrier (v) avoidance of organic solvents and (vi) no 
problems with respect to large scale production and sterilization. 
 
Based on these facts, the aim of this work is to present current knowledge on essential oils 
with special focus on mechanism of antimicrobial action; assessment of their efficacy as 
preservatives in cosmetic formulations as well as their safety is carried out with the following 
objectives.  
 
 Selection of Natural Preservatives/ Oils 
 Optimization of Natural Preservatives/ Oils in various Bacterial strains. 
 Determine the Minimum inhibitory Concentration of essential oils. 
 The specific objective of the present work is to develop nano structured lipid carriers 
(NLC’s) loaded with  Tetrahydrocurcumin (THC) using Natural Preservatives 
(Natural Essential Oils) 
 To optimize the developed NLC loaded with THC 
 To characterize the prepared formulations 
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REVIEW OF LITERATURE 
NANO STRUCTURED LIPID CARRIERS; POTENTIAL DRUG CARRIERS 
In the pharmaceutical breakthrough today, the new technologies lead to find 
numerous new mighty compounds. To double-check progress in drug therapy the 
development of new drugs solely is not sufficient. Poor water solubility and insufficient 
bioavailability of the new drug substances are very widespread issues encountered. Thus, 
there is an expanding need to develop a pharmaceutical carrier scheme that overcomes these 
matters. This carrier scheme should be free of toxicity, have an adequate pharmaceutical 
loading capability and the possibility of pharmaceutical targeting and controlled release 
characteristics. The system should provide chemical and personal steadiness for the 
incorporated pharmaceutical. The feasibility of the production technique and as well the 
affordability should also be accessible. 
SLN have been presented as an alternate carrier scheme to emulsions, liposomes and 
polymeric nanoparticles. SLN are formulated from solid lipids only. Therefore, after 
groundwork at smallest a part of the particles crystallizes in a higher energy modification (α 
or β`). Throughout storage, these modifications can transform to the low power, more 
organised β modification. Due to this modification high degree of alignment, the number of 
imperfections in the crystal lattice is small; this directs to drug expulsion .NLC have been 
developed to overwhelm the drawbacks affiliated with SLN. They are advised to be the 
second lifetime of lipid nanoparticles. Contrasted to SLN, NLC show a higher loading 
capability for hardworking compounds by conceiving a less organized solid lipid matrix, i.e. 
by blending a fluid lipid with the solid lipid, a higher element drug stacking can be achieved. 
NANO TECHNOLOGY AND NANO MEDICINE 
Nanotechnology is extremely valuable in the development of advanced therapeutic 
systems, which are termed “nanomedicines”. In particular, drug delivery systems using 
nanoparticles area promising approach to improving the safety and bioavailability of drugs. 
Strongly lipophilic compounds are not generally applicable in aqueous biological systems. 
However, even if a drug is water insoluble, drug delivery materials permit its solubilization in 
the form of nanoparticle dispersions. Furthermore, targeted delivery of drugs to tissues and 
cells, as well as controlled release of the drug, are possible by varying the properties of these 
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nanoparticles. Thus, nanoparticulate drug delivery systems may lead to the development of 
novel therapeutic agents toward nanomedicine. 
Approaches for the Development of Solid and Semi-Solid Lipid-Based Formulations 
Lipid Based Drug Delivery (LBDD) has developed over the past decade fuelled by a 
better understanding of the multiple roles lipids may play in enhancing oral bioavailability. 
Moreover, the emergence of novel excipients with acceptable regulatory and safety profiles 
coupled with advances in formulation technologies have greatly improved the potential for 
successful lipid based formulations. With the growing interest in this field, there is an 
increasing need for guidelines in excipient selection and characterization; material handling, 
formulation design, and processing techniques to obtain effective and patient-compliant 
dosage forms. V. Jannin et al 2007 present the recent approaches in selecting the most 
appropriate lipid system(s); methods for characterization of their behaviour in vitro and in 
vivo. 
Nutraceuticals 
The term "Nutraceutical" was coined by combining the terms "Nutrition" and 
"Pharmaceutical" in 1989 by Dr Stephen DeFelice, Chairman of the Foundation for 
Innovation in Medicine. About 2000 years ago, Hippocrates correctly emphasized “Let food 
be your medicine and medicine be your food". Currently there is an increased global interest 
due to the recognition that “nutraceuticals” play a major role in health enhancement. 
Presently over 470 nutraceutical and functional food products are available with documented 
health benefits. “Nutraceuticals and functional foods have received considerable interest 
because of their presumed safety and potential nutritional and therapeutic effects” A 
Rajasekaran et al., (2008). Nutraceuticals have been claimed to have a physiological benefit 
or provide protection against the following diseases (and/or found to act as) 
 Cardiovascular agents 
 Antiobese agents 
 Antidiabetics 
 Anticancer agents 
 Immune boosters 
 Chronic inflammatory disorders 
 Degenerative diseases 
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Nano Structured lipid carriers (NLC) 
Solid lipid nanoparticle (SLN) and nanostructured lipid carrier (NLC) are colloidal 
lipid systems, which have been proposed for several administration routes, such as parenteral, 
oral and topical route providing controlled release profile of many substances. Solid lipid 
nanoparticle (SLN) has the chance to be exploited as a delivery system in commercial 
products. However, there are some limitations of the solid lipid nanoparticles (SLN) system: 
Drug expulsion phenomenon when lipid crystallizes to the stable β-form, particle 
concentration in the aqueous dispersions ranging from about 1% to a maximum of only 30% 
and limitation of drug load by the solubility of the drug in the solid lipid(A.C. Silva, 
Aakanchha Jain et al.,2011). These limitations were solved by creating a lipid particle with a 
controlled nanostructure i.e the nano structured lipid carrier (NLC). 
SLN consists of pure solid lipids and NLC contains a certain percentage of additional 
liquid lipids leading to imperfections in the crystal lattice. These nanoparticles are produced 
by one of the following techniques, namely, high pressure homogenization, microemulsion 
template, cold homogenization, solvent emulsification, solvent diffusion, reverse micelle-
double emulsion, homogenization followed by ultrasonication, solvent injection and a very 
recently introduced membrane contractor techniques(Amichand Dairam et al.,2008) 
The suitability of solid lipid nanoparticles (SLN) for the encapsulation of lipophilic 
drug was assessed for oral administration. The hot high pressure homogenization (HPH) 
technique was used as production method for SLN. Mechanical approaches are capable of 
producing nanoparticles, typically in the 100–1000 nm range, whereas chemical methods 
tend to produce 10–100 nm particles. (A.C. Silva et al.,2011) 
Nanotechnology is an enable technology that has the potential to revolutionize drug 
and food systems. Nanotechnology have shown enhanced oral bioavailability and biological 
efficacies of different phytochemicals (HuangQ et al. 2010) 
Tetrahydrocurcumin bioavailability 
Curcumin, a polyphenolic compound extracted from the rhizomes of turmeric 
(Curcuma longa Linn.), has a wide biological and pharmacological profile. It has also been 
reported to possess anti-oxidative, anti-inflammatory, anticarcinogenic, and gastroprotective 
Review of Literature Nutricosmetics 
 
 
14 
 
effects (Ruby AJ et al.,). Tetrahydrocurcumin (THC), one of the major metabolites of 
curcumin invivo (Pan MH et al.,) was reported to exhibit the same physiological and 
pharmacological properties of curcumin. THC has been widely used in pharmaceutical and 
cosmetic preparations. THC, in a white to off-white powder form, has a molecular weight of 
372.41 Da and a melting point of 85–100°C. THC is insoluble in water and soluble in 
alcohol, acetone, and glacial acetic acid. However, the pharmacological effect of THC is 
limited due to its low aqueous solubility. In addition, a relative short gastric emptying time 
can result in an incomplete release of THC from the dosage form at the site of absorption and 
lead to a diminished efficacy of the administered dose. 
 Based on the available literatures the therapeutic potential of THC can be achieved by 
making it as NLC formulation with improved bioavailability. The present investigation is 
focused on the development of THC nanostructure Lipid carrier with enhanced 
bioavailability.  
ANTIBACTERIAL ACTIVITY OF ESSENTIAL OILS AND POTENTIAL 
APPLICATIONS IN FOOD 
Essential oils are aromatic oily liquids obtained from plant material (flowers, buds, seeds, 
leaves, twigs, bark, herbs, wood, fruits and roots). They can be obtained by expression, 
fermentation or extraction but the method of steam distillation is most commonly used for 
commercial production of EOs (Helander .I M et al.,1998). The term 'essential oil' is thought 
to derive from the name coined in the 16th century by the Swiss reformer of medicine. An 
estimated 3000 EOs are known, of which about 300 are commercially important – destined 
chiefly for the flavours and fragrances market. It has long been recognised that some EOs 
have antibacterial properties and these have been reviewed in the past that spices have 
antibacterial properties. Besides antibacterial properties, EOs or their components have been 
shown to exhibit antiviral, antimycotic, antitoxigenic, antiparasitic, and insecticidal 
properties. 
 
The greatest use of EOs in the European Union (EU) is in food (as flavourings), perfumes 
(fragrances and aftershaves) and pharmaceuticals (for their functional properties). The well-
known use of EO in aromatherapy constitutes little more than 2% of the total market. 
Individual components of EOs are also used as flavourings, either extracted from plant 
material or synthetically manufactured. The antibacterial properties of essential oils and their 
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components are exploited in such diverse commercial products as dental root canal sealers, 
antiseptics and feed supplements for lactating sows and weaned piglets. A few food 
preservatives containing Eos (Sara Ann Burt et al.,2007).  
Recently there has preservative and antimicrobial role of spices has been an 
increasing interest in discovering new natural prevention of meats. Bio preservatives include 
a range of natural plants, animals and microorganisms which can be used to improve the 
keeping quality of foods. Being plant natural food stuffs, spices appear to be an alternative 
for the chemical antimicrobials to the consumers who tend to question their safety. Spices 
active compounds have been included in class of naturally occurring food preservatives and 
their inclusion in foods allowed by food production regulatory offices. Although, spices have 
been well known for their medicinal, preservative and antioxidant properties, currently they 
have been used with primary purpose of enhancing the flavour of foods rather than extending 
shelf-life. In recent years antimicrobial properties of spices have been documented and 
interest continued to the present. There is little information available emphasizing the 
preservative and antimicrobial role of spices in the prevention of meat (A. Jagadeesh Babu et 
al.,2011)   
 
ESSENTIAL OILS AS NATURAL COSMETIC PRESERVATIVES 
 
Nowadays, safety of chemical preservatives has been questioned by a big number of 
consumers. Traditionally used preservatives often cause skin irritation and lead to allergenic 
reactions. Growing demands for more natural and preservative-free cosmetics promoted an 
idea of the replacement of synthetic preservatives with essential oils (EOs) of antimicrobial 
properties. The antimicrobial effect of essential oil depends on content, concentration and 
interactions between the main active compounds. Effective preservatives should be 
characterized by a broad spectrum of antimicrobial activity at a minimum concentration. 
Formulations containing both types of preservatives: essential oil and a synthetic one have 
been tested and proposed as a compromise that allows for reducing concentration of both 
components due to their synergistic activity. Although most essential oils are regarded as 
safe, some of them may cause risk of contact allergy or phototoxic reaction. (Mariola Dreger, 
Karolina wiergus et al.,2013). 
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EOs are obtained using several techniques:- water or steam distillation, solvent extraction, 
expression under pressure, supercritical fluid or subcritical water extractions. 
 
Nowadays, essential oils are the subject of intensive scientific research and also attract 
attention of cosmetic and pharmaceutical industries due to their potential as active 
pharmacological compounds or natural preservatives. Enormous diversity of this group of 
natural compounds and wide spectrum of biological properties make them attractive for many 
industries and new areas of application still has not been discovered. Regardless from sensory 
properties of essential oils, antimicrobial and antifungal activities are the goal of research. A 
new promising field of application of essential oils as natural preservatives in cosmetics or 
feed additives in human or animal food or as plant protection products has been studied. It is 
estimated that more than 3000 essential oils are of commercial importance and used in 
flavour and cosmetic industries. Trade of the most popular oils such as eucalyptus or lemon 
ones was calculated at over 1000 metric tons a year and their estimated value is several 
hundred million Euros. 
 
The microbial safety of cosmetics has been always of special interest for industries, as 
microbial spoilage can lead to product degradation and cause a risk for consumers health. 
Rich composition of modern cosmetics in combination with aqueous formulation and direct 
exposure to bacterial skin flora make them an ideal environment for growing of 
microorganisms. Taking into consideration the high risk of contamination and therefore a risk 
for consumers health, the use of preservatives is a necessity. Moreover, bacterial 
contamination changes physical and chemical properties of cosmetics usually resulting in 
phase separation, discoloration and release of odours etc. Preservation systems prevent and 
control the growth of microorganisms from contamination during manufacturing, storage or 
consumer use (Mariola Dreger, Karolina wiergus et al.,2013). 
 
MECHANISM OF ANTIMICROBIAL ACTION OF ESSENTIAL OILS 
 
Antimicrobial activities of EOs are well known and documented in numerous works. They 
are effective against both saprophytic bacteria and fungi, which are main source of cosmetic 
contaminations (Bacillus sp., Micrococcus sp., Aereomonassp., Acinetobacter sp. and 
Aspergillus sp. or Penicillium sp.) and also against human pathogens (Staphylococcus sp., 
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Streptococcus sp., Salmonella sp. or Candida sp. And others). In contrast to antimicrobial 
activity of EOs mechanisms of their action are still not fully understood and need elucidation. 
In general, antimicrobial activity of essential oils is determined by their composition and 
concentration of components. The number of constituents in essential oil can range from 
several up to far more than 100. Composition and proportion of compounds varies and 
depends on chemotype, age of a plant, climatic and environmental conditions as well as 
harvest time and the distillation method. Essential oils are a complex and diverse group of 
natural compounds that usually consist of terpenes with terpenoids, and also aromatic and 
aliphatic compounds of low molecular weight. Monoterpenes are the most commonly found 
molecules constituting 90% of essential oils in a great variety of structures. Aromatic 
compounds are represented less frequently, usually in trace amounts. EOs composition is 
often characterized by two or three main compounds at higher concentrations (20–70%), 
which determine biological properties of essential oil. 
 
EFFICACY OF ESSENTIAL OILS AS PRESERVATIVES IN COSMETIC 
FORMULATIONS 
 
Efficacy of preservatives in cosmetic formulations is evaluated in a challenge test according 
to the European Pharmacopoeia guidelines. The challenge test is a standard procedure that 
involves artificial contamination of cosmetics with predetermined number of bacteria and 
fungi (105-106 viable cells ml-1 or g-1 of product) as well as periodic removal of samples at 
fixed time for counting of viable microorganisms present in the formulation during test. 
Microorganisms used in the challenge test include strains of bacteria: Staphyllococcus 
aureus, Pseudomonasaeruginosa, Escherichia coli and fungi: Aspergillus niger and Candida 
albicans. According to EP, a topical preparation is well preserved if the number of the 
bacteria recovered per gram is reduced by a factor of 103 (criteria A) and 102 (criteria B) 
within 2 days of the challenge test with no cell proliferation at 7th day up to the 28th day 
(Mariola Dreger, Karolina wiergus et al.,2013).. 
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PLAN OF WORK 
 Preformulation Studies 
 Preparation of Calibration Curve for Tetrahydrocurcumin (THC) by UV 
Visible Spectrophotometric Analysis 
 IR Spectroscopic Analysis 
 Selection of Natural Preservatives/ Oils 
 Optimization of Natural Preservatives/ Oils in various Bacterial strains. 
 Determine the Minimum inhibitory Concentration of essential oils. 
 
 Formulation Development 
 Formulation of nano structured lipid carrier using Ultra probe sonication 
technology 
 Formulation of Base Cream and Carbopol Gel 
 Incorporation of NLC into Base Cream and Carbopol Gel 
 
 Characterization studies of the NLCs prepared 
 Particle Size Determination by Zeta sizer  
 Atomic Force Microscopy(AFM) 
 Scanning Electron Microscopy(SEM) 
 Phase Contrast Microscopy(PCM) 
 In vitro skin penetration 
 Texture Analysis 
 Stability Studies as per ICH guidelines 
 
Materials & Equipments Nutricosmetics 
 
19 
 
MATERIALS USED 
Table 1: 
SL.NO. MATERIALS SOURCE 
1. Tetra Hydro Curcumin Sami labs, Bangalore 
2. Stearic Acid Loba Chemie Pvt. Ltd., Mumbai 
3. poloxamer Himedia lab., mumbai 
4. Polyethylene Glycol 400 Himedia Lab., Mumbai 
5. Glyceryl mono stearate Loba Chemie Pvt. Ltd., Mumbai 
6. Tween 80 Loba Chemie Pvt. Ltd., Mumbai 
7. Cinnamon oil pure Sangrose Laboratories Pvt. Ltd., Mavelikara 
8. Methanol Himedia Lab., Mumbai 
9. Sodium Lauryl Sulphate Sangrose Laboratories Pvt. Ltd., Mavelikara 
10. Ceto stearyl alcohol Loba Chemie Pvt. Ltd., Mumbai 
11. Cetyl alcohol Loba Chemie Pvt. Ltd., Mumbai 
12. Myristic acid Loba Chemie Pvt. Ltd., Mumbai 
13. Palmitic acid               Himedia Lab., Mumbai 
14. Distilled Water               Himedia Lab., Mumbai 
15.  Muller Hinton Agar     Himedia Lab., Mumbai 
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 EQUIPMENTS USED 
Table 2: 
SL.NO. EQUIPMENT MODEL/COMPANY 
1. Digital Weighing Balance Shimadzu AY 220 
2. Magnetic Stirrer Remi Equipments Ltd 
3. Bath Sonicator RP 120 Ralsonics, Mumbai 
4. Ultra Probe Sonicator SONICS vibracell 
5. UV Visible Spectrophotometer UV-1650 PC Shimadzu 
6. FT IR Spectrophotometer 8400 S Shimadzu 
7. IR Hydraulic Pellet Press Model M15 Technosearch Instruments 
8. ELIZA reader Thermo Scientific 
9. Scanning Electron Microscope JEOL, Japan- JSM 6360 
10. Atomic Force Microscope  Multimode Scanning probe microscope 
(NTMDT, NTEGRA prima, Russia) 
11. Zeta Sizer Nano ZS90 Malvern UK 
12. Texture Analyzer TA-XT Plus 
13. Phase Contrast Microscope NIKON Inverted Fluorescent Microscope 
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DRUG PROFILE 
TETRAHYDROCURCUMIN (THC) 
Chemical name                      : 1,7- bis (4-hydroxy 3 methoxy phenyl)-3,5 heptanedione 
Formula        : C21H24O6 
Structure   :  
Molecular weight  : 372.41 Da 
Physical state   : Solid 
Melting point   :           95-97oC 
Solubility             :  Water solubility- 0.0056 g/ l, freely soluble in  
acetone, glacial acetic acid 
Log P    : 3.51 
Log S    : -4.82 
Pka (strongest acidic) :  9.31 
Pka( strongest basic)  :           -4.6  
Hydrogen acceptor count : 6 
Hydrogen donor  : 2 
Polar surface area  : 93.06 A2 
Pharmacological actions : THC exhibits many of the pharmacological actions as  
that of curcumin. It has got many potent 
pharmacological actions like anti-oxidant property, anti-
cancerogenic and anti-angiogenic and prevents type II 
diabetes. It was also proved to be more effective than 
curcumin in preventing azoxymethane-induced colon 
carcinogenesis. 
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EXCIPIENTS PROFILE 
STEARIC ACID 
Synonyms : Acidum stearicum; cetylacetic acid 
Chemical Name : Octadecanoic acid  
Empirical Formula : C18H36O2 
Structural Formula     : 
 
Molecular Weight : 284.47 (pure material) 
  The USP32–NF27 describes stearic acid as a mixture of stearic 
acid (C18H36O2) and palmitic acid (C16H32O2).  
Functional Category : Emulsifying agent; solubilising agent; tablet and capsule    
lubricant. 
Applications  :  Widely used in oral and topical pharmaceutical formulations; 
mainly used in oral formulations as a tablet and capsule lubricant; 
may be used in enteric tablet coatings and as a sustained-release 
drug carrier; In topical formulations, stearic acid is used as an 
emulsifying and solubilising agent; the partially neutralized 
stearic acid forms a creamy base when mixed with 5–15 times its 
own weight of aqueous liquid; also widely used in cosmetics and 
food products. 
Description :  A hard, white or faintly yellow-colored, somewhat glossy, 
crystalline solid or a white or yellowish white powder; has a 
slight odour (with an odour threshold of 20 ppm) and taste 
suggesting tallow. 
Melting point :  69–70°C 
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Solubility  :  Freely soluble in benzene, carbon tetrachloride, chloroform and 
ether; soluble in ethanol (95%), hexane, and propylene glycol; 
practically insoluble in water. 
Stability and Storage 
Conditions : A stable material; an antioxidant may also be added to it; the bulk 
material should be stored in a well closed container in a cool, dry 
place. 
Incompatibilities : Stearic acid is incompatible with most metal hydroxides and may 
be incompatible with bases, reducing agents, and oxidizing 
agents. Ointment bases made with stearic acid may show 
evidence ofdrying out or lumpiness due to such a reaction when 
compounded with zinc or calcium salts. 
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TWEEN 80 
Synonyms  : Polysorbate 80 
Chemical name  : Polyoxyethylene 20 sorbitan monooleate 
Empirical formula  : C64H124O26 
Molecular weight  :  1310 
Structural formula  : 
 
Functional category  : Dispersing agent; emulsifying agent; non-ionic surfactant; 
solubilising agent; suspending agent; wetting agent 
Boiling point  : More than 100oC 
Solubility  : Soluble in water and ethanol 
Stability and storage  : Polysorbates are stable to electrolytes and weak acids and 
bases, gradual saponification occurs with strong acids and 
bases. The oleic acid esters are sensitive to oxidation. 
Polysorbates are hygroscopic should be examined for water 
content prior to use an dried if necessary. Also, in common 
with other polyoxyethylene surfactants, prolonged storage 
can lead to the formation of peroxides. Polysorbates should 
be stored in a well-closed container, protected from light, in a 
cool, dry place. 
Safety          : Moderately toxic by IV route; mildly toxic by ingestion; eye 
irritation. 
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GLYCERYL MONOSTEARATE 
Synonym   :   Glyceryl monostearate, Glycerin monostearate, Monostearin 
Chemical name  :   2,3-Dihydroxypropyl octadecanoate 
Empirical formula  :   C21H42O4 
Molecular weight  :   358.56 g·mol−1 
Structural formula  :  
 
  
Description   :   A white or yellowish white, hard waxy mass or unctuous  
    powder or flakes; odourless or slight, agreeable, fatty odour. 
 
Boiling point   :    238 to 239 °C  
Melting point   :    58 to 59 °C  
Functional category  :   GMS is a food additive used as a thickening, emulsifying,  
anti-caking, and preservative agent; an emulsifying agent for           
oils, waxes, and solvents; a protective coating for 
hygroscopic powders; a solidifier and control release agent 
in pharmaceuticals; and a resin lubricant. It is also used in 
cosmetics and hair care products. It is responsible for 
giving ice cream and whipped cream its smooth texture. It is 
sometimes used as an anti-staling agent in bread. 
Storage   :    Glyceryl monostearate should be kept in a tightly closed  
          container, protected from light. 
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CINNAMON OIL 
Synonym                   :   Cassia oil, Chinese cinnamon,Cassia bark   oil, Oil of cassia   
Chemical name  :   2-methoxy-4-prop-2-enylphenol;[(E)-prop-1-enyl]benzene 
 
Empirical formula  :   C19H22O2 
Molecular weight  :   282.383 g/mol 
Structural formula  :  
                                           
                               
Description  :   It is of a golden-yellow colour, with the characteristic odour  
of  cinnamon and a very hot aromatic taste. The pungent and    
scent come from cinnamaldehyde (about 90% of the 
essential oil from the bark) and, by reaction with oxygen as 
it ages, it darkens in colour and forms resinous compounds. 
Boiling point   :   194-234 °C 
 
Solubility   :   Insoluble in water, soluble in alcohol  
Functional category  :   Effective at treating skin conditions such as rashes, acne and     
infections, you can mix cinnamon essential oil with a 
carrieroil (like coconut oil) and apply it to the skin to take 
advantage of its antimicrobial capacity. 
Preformulation Nutricometics 
 
27 
 
PREFORMULATION STUDIES 
Preformulation studies involve physical, chemical and biological characterization of 
new drug substances in order to develop stable, safe and effective dosage form. 
Preformulation testing encompasses all studies enacted on a new drug compound in order to 
produce useful information for subsequent formulation of a stable and bio-pharmaceutically 
suitable drug dosage form. 
Analytical methods for Tetrahydrocurcumin (THC) 
 UV Spectrophotometric estimation of Tetrahydrocurcumin  (European 
Pharmacopoeia 6.0) 
Determination of lambda max: 
Tetrahydrocurcumin: 
A concentration of 100μg/ml solution of THC, were prepared and scanned under UV 
Visible Spectrophotometer from 200 to 400nm. The corresponding peak with the highest 
absorbance was taken as the lambda max for quantifying THC.  
Tetrahydrocurcumin standard solution (100μg/ml) showed highest peak at 281nm. 
From the UV-Vis spectrum (Graph 1) the lambda max of the THC was optimized as 281nm 
and used for further studies. 
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Lambda max of Tetrahydrocurcumin:  
Fig 3 :  UV Spectrum of Tetrahydrocurcumin 
 
Compatibility studies 
The sample of tetrahydrocurcumin of about 10mg was mixed with 100mg of KBr to 
make the pellet and scanned under FT-IR spectroscopy from 400 – 4000 cm-1. 
IR Spectrum of Tetrahydrocurcumin  
Characteristic peaks for carbonyl group C=O stretching was observed in 1603 cm-
1and C-OH Stretching at 1156 cm-1 which is evident that two peaks are confirming the purity 
of tetrahydrocurcumin molecule.  
IR spectra of physical mixture of THC and stearic acid 
The characteristic peaks for C=O and C-OH at 1603 and 1156 was observed in the IR 
spectra of physical mixture of drug and lipid. This confirms that the molecule under study, 
THC has not undergone any structural changes. Thus no incompatibility issue is observed 
with the lipid used. 
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Fig 4 :  IR Spectra of Tetrahydrocurcumin 
 
 
Fig 5: IR spectra of physical mixture of THC and stearic acid 
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SOLUBILITY STUDIES  
Apparent Solubility study 
THC (5mg) was added to 1.5ml of various medium like water, 0.5-3%SLS in water, 
pH 7.4, 0.5-3%SLS in pH7.4, pH6.8, 0.1N HCl and kept in thermo mixer maintained at 370C 
for 1hr.Samples were then analyzed spectrophotometrically  at 281nm. The results are shown 
in fig 6. 
    
 
 
The solubility of the Tetrahydrocurcumin was found to be higher in SLS solution while 
compared to water .Therefore, the calibration curve was constructed using 1% SLS in water 
solution. 
 
Fig 6 : Graph showing solubility of drug in different solutions 
 
Table 3: Solubility Profile of Tetrahydrocurcumin 
Drug Solvent Concentration(mg/ml) 
THC 1% SLS 4.125 
SPECTROPHOTOMETRIC 
             ANALYSIS 
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Calibration Curve  
1% solution of Sodium Lauryl Sulphate (SLS) in pH 7.4 was used as the buffering 
medium in the preparation of standard solution of Tetrahydrocurcumin  
 
Standard graph for THC 
 Primary stock solution of THC was prepared by dissolving 10mg of THC in 100ml of 
methanol in a volumetric flask. Aliquots of THC was prepared from stock solution in the 
concentration range of 2 μg/ml, 4 μg/ml, 6 μg/ml, 8 μg/ml and 10 μg/ml in 100ml volumetric 
flask using 1%SLS in buffer as solvent. The absorbance of THC standard solutions was 
measured at 281 nm (lambda max of THC) against 1% SLS in buffer solution as blank. The 
standard graph was prepared with concentration of solution (in µg/ml) on X-axis and 
absorbance on Y-axis. The results are shown in fig 8.  
Table 4: Standard Table for Tetrahydrocurcumin 
Sl.no Concentration (µg/ml) Absorbance at 281nm 
1.  2 0.090 
2.  4 0.151 
3.  6 0.214 
4.  8 0.279 
5.  10 0.336 
  
Fig 7: Calibration Curve of Tetrahydrocurcumin 
 
 
 
 
 
 
 
EXPERIMENTAL METHODOLOGY 
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SELECTION OF OILS 
Various Essential oils have been widely used for bactericidal, virucidal, fungicidal, 
ant parasitical, insecticidal, and other medicinal properties such as analgesic, sedative, anti-
inflammatory, spasmolytic, and locally anesthetic remedies. Essential oils  such as Neem oil, 
Clove oil, Eucalyptus oil, Orange oil, Peppermint Oil, Lemon grass Oil, Castor oil, Lavender 
Oil, Olive oil, Cinnamon oil tested for antibacterial activity against 7 Bacterial Strains.  
(Staphylococcus aureus, Enterococcus faecalis, Streptococcus aeruginosa, Salmonella 
typhimurium, E.coli, Klebseilla pneumonia, Candida albicans). 
Various 
Essential 
oils 
Strains 
Staphylococcus 
Aureus  
Solmonella 
typhimurium 
Enterococcus 
faccalis 
Pseudimonas 
aeroginosa 
E.coli Klebsiella 
pneumonia 
Candida 
albicans 
Neem oil 
Oil 
-- -- -- - -- -- -- 
Clove Oil     -       - 
Eucalyptus 
Oil 
    -       - 
Orange Oil - - - - - - - 
Peppermint 
Oil 
    -       - 
Lemon 
Grass Oil 
 -   -         
Castor Oil - - - - - - - 
Lavender 
Oil 
    -         
Olive Oil - - - - - - - 
                                
  Table 5: Antibacterial activity of Essential Oils 
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                    Fig 8 : Images Of Zone Of Inhibition For Essential Oils 
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Among this clove oil, peppermint oil, lemon grass oil, lavender oil, Cinnamon oil have well 
effect against bacteria. Neem oil has less bacterial activity presents in the active constituent 
of neem bark oil other than that it has fungal activity. 
 
 
 
 
Mixed proportions of essential oils were studied for antimicrobial activity for E.Coli 
and Klebsiella strains  
 
 
Clove Oil + Eucalyptus Oil Clove Oil + Lavender Oil 
Clove Oil + Peppermint Oil Eucalyptus Oil + Peppermint Oil 
Peppermint Oil + Lavender Oil Clove Oil + Eucalyptus Oil + 
Peppermint Oil 
Clove Oil + Eucalyptus Oil + 
Peppermint Oil + Lavender Oil 
Clove Oil + Eucalyptus Oil + 
Peppermint Oil + Neem Oil 
Clove Oil + Eucalyptus Oil + 
Peppermint Oil + Lavender Oil + 
Neem Oil 
Cinnamon Oil + Neem Oil 
      
                                    Table 6: Mixed Proportion Of Essential Oils  
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                            Fig 9: Images of Zone of Inhibition For Mixed Proportion 
Here combination of oils shows lesser antibacterial activity than individual. 
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DETERMINATION OF MINIMUM INHIBITORY CONCERNTRATION 
Method: 1  
 MIC determinations were performed in 96-well micro plates according to procedures 
described by the Clinical and Laboratory Standards Institute. The liquid media was prepared 
by adding 2% peptone, 0.5% Nacl, 0.3% beef extract in 100ml distilled water. Then 100µl 
liquid media was transferred into micro plate well. 100µl of essential oil were added in first 
well then serial two fold dilution was made. Add 5µl inoculum in each well.  The positive 
control comprised of media and organism and the negative control was liquid media. 
Inoculated micro plate were incubated for 24hrs at 37°C. Then absorbance were measured 
spectrometrically at 625 nm.      
              
Control Absorbance 
Media 0.0470 
Media + Organism 0.1156 
                           
 
 
Essential oil 
 
1 
 
2 
 
3 
 
4 
 
5 
 
6 
 
7 
 
8 
 
9 
 
10 
 
11 
 
Cinnamon oil 
 
0.1956
1956 
 
0.4966 
 
0.4074
0.4074 
 
0.2406
0.2406 
 
0.0921
0921 
 
0.0913
913 
 
0.0777
0.0777 
 
0.0843
843 
 
0.0751 
51 
 
0.0928
928 
 
0.0711.
0711 
 
Eucalyptus oil 
 
0.0568 
 
0.0791 
 
0.0736 
 
0.0768 
 
0.0786 
 
0.0999 
 
0.1606 
 
0.1432 
 
0.1417 
 
0.1314 
 
0.1382 
 
Peppermint oil 
 
0.6197 
 
0.1587 
 
0.0968 
 
0.0962 
 
0.0902 
 
0.1201 
 
0.1071 
 
0.1225 
 
0.1244 
 
0.1443 
 
0.1291 
 
Lavender oil 
 
0.2285 
 
0.1144 
 
0.1425 
 
0.0783 
 
0.1368 
 
0.1970 
 
0.1752 
 
0.2272 
 
0.1981 
 
0.2594 
 
0.1268 
 
                     Table 7:  Minimum inhibitory concentration for essential oils  
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Method :2  
 
All microbiological assays were performed under anaerobic conditions. MIC 
determinations were performed in 96-well micro plates according to procedures described by 
the Clinical and Laboratory Standards Institute. Each essential oil (200mg) was dissolved in 
dimethyl sulfoxide (40µL) and the volume was made to 5 mL with sterile Muller Hinton 
medium containing 1% Tween 80 to provide a stock solution containing 40 mg mL–1of oil. 
Serial two fold dilutions of each essential oil stock were made with Muller Hinton medium to 
yield final concentrations ranging from 20 to 0.625 mg mL–1. The diluted samples (100 µL) 
were transferred to micro plate wells and mixed well with the micropipette. The negative 
controls comprised sterile Muller Hinton medium or with dimethyl sulfoxide (at 
concentrations used in the dilutions). In order to ascertain aseptic conditions, the control 
wells contained sterile Muller Hinton medium but without inoculum. The inoculated micro 
plates were incubated at 36 ± 1◦C for 48h under anaerobic conditions; and the bacterial 
growth was confirmed by adding 10µL of a sterile 0.5% aqueous solution of triphenyl 
tetrazolium chloride (TTC,Sigma–Aldrich) and incubating at 36◦C for 30min. The viable 
bacterial cells reduced the yellow TTC to pink/red 1,3,5-triphenylformazan (TPF). All assays 
were performed in triplicate. 
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              Fig 10:  Minimum Inhibitory Concentration for Peppermint Oil   
  
               Fig 11:  Minimum Inhibitory Concentration for Cinnamon Oil, Lavender Oil  
                                                                           And Eucalyptus Oil 
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EXPERIMENTAL METHODOLOGY 
Nanostructured lipid carriers (NLC) are the second Generation solid lipid nano 
particles (SLN) composed of solid lipid matrix which are incorporated with liquid lipids. 
Among the nanostructured lipid carriers that contain solid lipids together with different liquid 
oils .The presence of liquid lipids with different fatty acid C-chains produces NLC with less 
organized crystalline structure and therefore provides better loading capacity for drug 
accommodation. Liquid lipids are better solubilizers of drugs than solid lipids. 
Approaching nano structured lipid carrier development from an emulsion perspective 
is faced with significant challenges. Numerous research groups subsequently commenced 
research efforts to improve nano structured lipid carrier development. Most researchers have 
approached traditional emulsion techniques.  
MATERIALS 
  Stearic acid, tween 80, Glyceryl monostearate, Cinnamon oil,  
 
FORMULATION DEVELOPMENT 
Preparation of Nano Structured Lipid Carriers (NLC) by High Shear 
Homogenization coupled with ultra probe sonication 
 The solid lipid (500mg) of choice and the liquid lipid (0.3ml)was mixed with the drug 
(100mg) and warmed to 75°C for effective melting and mixing. Simultaneously, distilled 
water (20ml) to which the surfactant (0.5ml) has been incorporated is also heated to 75°C,it is 
instilled into the formulation herein. Thereafter, the aqueous part is added to the lipid part 
maintaining the temperature at 75°C, with continous stirring followed by magnetic stirring for 
20mins. The two- phase system is then sonication using probe sonicator, at 20,000 rpm for 10 
min followed by ultra sonication for 2 min. The prepared formulations are stored at 
refrigeration condition until further use. 
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         Fig 12 :Schematic representation of the configuration of a Ultra Probe Sonicator 
Preparation of Base Cream: 
In this study, W/O emulsion was prepared by the addition of aqueous phase to the oily 
phase with continuous agitation. To prepare the base, an lipid phase that consisted of cetyl 
alcohol (1%), ceto steryl alcohol (1%), palmitic acid (1%) and myristic acid (10%). At the 
same time, aqueous phase consisting of distilled water (82%), span60 (1.5%), tween80 (5%) 
was heated to the same temperature. After heating, aqueous phase was added to the lipid 
phase drop by drop. Stirring was continued at 2000 rpm by the mechanical mixer for 15 min 
until complete aqueous phase was added. After the complete addition of the aqueous phase, 
the speed of the mixer was reduced to 1000 rpm for homogenization,for a period of 5 min, 
and then the speed of the mixer was reduced to 500 rpm for further 5 min for complete 
homogenization, until the emulsion coolednto room temperature. 
Incorporation of NLC into Base Cream 
 Prepared THC loaded NLC formulation (10ml) was incorporated into the 10g of Base 
Cream.  
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CHARACTERIZATION STUDIES 
Particle size analysis  
 Photon correlation spectroscopy: 
The prepared SLN dispersions were diluted with water /suitable solvent and the 
sample were analyzed for particle size by photon correlation spectroscopy technique using 
Zeta sizer (Nano ZS 90), Malvern, UK.  
 Zeta potential 
The size distribution and the charge nature of the prepared solid lipid Nano particle 
loaded with nutraceuticals was analyze using Malvern zeta seizer. The suitable dilutions of 
the dispersions were made using water and it was scanned under version 6.30 by using 
disposable sizing cuvette at the count rate of 317.5 kcps for 60 sec at the measurement 
position of 4.6mm at attenuator 10. 
Atomic Force Microscopy 
A small aqueous drop of the THC loaded nanoparticles was adsorbed and dried to the surface 
of glass slide at room temperature. The images were examined on Multimode Scanning probe 
microscope (NTMDT, NTEGRA prima, Russia) in semi-contact mode with a force constant 
range of 0.35- 6.06 N/m and a resonating frequency range of 47- 150 KHz. The phase image 
and topology image were used to determine the morphology of the NLCs. 
Scanning electron microscopy 
           Scanning electron microscope (SEM) is a type of electron microscope that produces 
images of a sample by scanning it with a focused beam of electrons. The electrons interact 
with atoms in the sample, producing various signals that can be detected and that contain 
information about the sample's surface topography and composition. The surface 
characteristics of prepared NLC were examined by scanning electron microscope (SEM). The 
suspension was first put on clear glass stub, allowed to dry in air followed by coating with 
gold using Polaren E 5100 sputter coater and observed under microscope at 5.5x 
magnification. 
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In vitro drug release studies: 
 SLN  formulation 2ml was taken in Franz diffusion cell apparatus. A Pig ear skin was 
placed in a Frans diffusion cell containing 1% SLS buffer solution as medium at room 
temperature. At various predetermined intervals i.e., 0.50hr, 1hr, 2hr, 4hr, 8hr, 24hr, 48hr. 1ml 
of samples was withdrawn and replaced by buffer solution, to maintain the sink conditions. 
Cumulative % drug release in the samples were determined by measuring the absorbance 
under UV visible spectrophotometry and thereby extrapolating from the calibration curves. 
 
 
Texture analysis: 
 
   Fig 13: Texture Analysis Image for THC loaded Cream 
Determination Of Spreadability Of Cream: 
The spreadability of the cream was determined by means of Texture Analyser (TA.XT plus) 
equipped with 5 kg load cell using spredability rig as fixture (figure ). This fixture consists of 
a heavy duty platform, male cone and a female cone.  The Heavy duty platform was placed on 
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the base of the machine and locked in the desired position by tightening the screws. An empty 
female cone sample holder was placed in the base holder. The male cone probe was attached 
above the female cone such that the male cone fits almost all the way into the female cone 
sample holder and proper care is taken to align the cones in this position. The height of the 
male cone was calibrated against the female cone so that the starting point was 25.0mm above 
the female cone (2 mm form the tip of the male cone and the sample). After calibration the 
sample was placed in the female cone sample holder and the test was run. The values of 
firmness (g) and work of shear (g s) were noted down by running macros. 
Determination of Bloom Strength 
The bloom strength of the cream was determined by means of Texture Analyser (TA.XT plus) 
equipped with 5 kg load cell using a cylindrical probe of 0.5’’ diameter as fixture (figure ). 
The sample in the container was placed centrally on the platform beneath the cylindrical 
probe. After calibrating the height of the probe, the test was commenced. A trigger force of 10 
g was used for the study. The test results are obtaining by running the macro. 
Extrudability of Cream: 
The cream were incubated at room temperature for 2 h before measuring their extrudability using an 
HDP/FE forward extrusion cell of the TA-XT2 Texture Analyser equipped with a 5 kg load cell 
(Stable Micro Systems, UK). Prior to measurement, the cream were manually stirred and loaded (100 
g) into the cell. Compression force was measured at the following conditions: pre-test speed 1 mm/s, 
test speed 1 mm/s, trigger force 50 g, post-test speed 10 mm/s, compression distance 20 mm, outlet 
diameter of extrusion cell 3 mm. The average force after reaching a plateau (at 10-15 s) was used as an 
indicator. 
Stability studies: 
 Particle size analysis and entrapment efficiency studies were conducted for 3 month to 
evaluate the stability of the formulations. The stability studies were carried out according to 
ICH guidelines.  The SLN formulations was stored at two different conditions i.e, 5 ± 3˚C 
(refrigeration conditions) and 25 ± 2˚C (room temperature).   
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RESULTS AND DISCUSSION 
The profound success of lipid based formulations for highly potent, lipophilic 
drug molecules have gained focus in this research field from the perspective of 
pharmaceutical industries. To increase the success rate of these lipids based 
formulations, there is a need to understand the excipients role. In this line, the present 
study is carried out to develop nano structured lipid carrier using the selected lipid 
with surfactants. 
FORMULATION DEVELOPMENT 
 Selection of Lipid 
The lipid Stearic acid was selected randomly based on the stability data of the 
previously formulated Tetrahydrocurcumin solid lipid nanoparticles. The lipid 
showed high drug encapsulation with good stability was selected for further studies. 
Preparation of Nano Structured Lipid Carrier 
Ultra probe sonicator were used to formulate NLC of Tetrahydrocurcumin. 
Totally, 10 formulations were prepared using one lipid (Stearic acid), one surfactant 
(Tween 80). The formulae for the prepared NLCs were given in the table No 5 
 
 
 
 
 
 
 
 
Results & Discussion Nutricosmetics 
 
47 
 
Table 8: Batch specification of THC loaded NLC 
Formulation 
 
Drug Lipid 
(Stearic acid) 
Essential oil       Tween 
80 
PEG 4000 Polaxamer  
188 
GMS Remarks 
F1 - 1 gm 1ml -         0.3gm 0.3gm -         CREAMING ON STORAGE 
F2 - 0.5gm 1ml -         0.3gm         0.3gm - CREAMING ON ROOM      
TEMPERATURE 
F3 - 1 gm 0.5ml -         0.3gm         0.3gm -                  AGGREGATION 
F4 - 0.5 gm 0.3ml -         0.3gm         0.3gm                  FLOCCULATION 
F5 - 0.5 gm 0.3ml 0.3 ml         0.3gm - -                   AGGREGATION 
F6 - 1 gm 0.3ml -         0.3gm         0.3gm -                 PHASE INVERSION 
F7 - 0.5gm 0.5ml -         0.3gm         0.3gm -                 PHASE INVERSION 
F8 - 0.5gm 0.3ml 0.5ml - - -         CREAMING ON STORAGE 
F9  0.5gm 0.3ml 0.5 ml - - 0.1gm               GOOD EMULSION 
F10 0.1gm 0.5gm 0.3ml 0.5 ml - - 0.1gm               GOOD EMULSION 
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Fig 14: Formulation of THC loaded NLC 
PHYSICOCHEMICAL CHARACTERIZATION 
Particle Size Analysis 
The prepared nano structured lipid carrier was subjected to particle size 
analysis using Zeta sizer (nano ZS90, Malvern, UK). The formulations were 
sufficiently diluted with double distilled water prior to the measurement. The results 
showed that the particle size of prepared formulations were in the range of 73 to 828 
nm with good PDI.  
 The results suggest that the incorporation of different surfactant showed a 
difference in the aggregation pattern of prepared particles. This may be due to the 
difference in the solubility of lipid in surfactants. 
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Table 9: Particle size measurement results of THC loaded NLC 
Formulation Particle Size (nm) PDI 
THC F10 246.7 0.385 
 
Size distribution report by intensity 
 
Zeta potential report 
 
Fig 15: Zeta size analysis of THC loaded NLC prepared using Stearic 
acid, 0.5 ml Tween 80 and 0.3ml Cinnamon oil 
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Phase Contrast Microscopy 
The Phase Contrast Microscope images for THC loaded NLC formulation, 
Formulation loaded cream shows particles are uniformly dispersed and it has 
spherical shape. 
 
   Fig 16: PCM images showing the morphology of THC loaded NLC 
                  
                                                      THC F10 – 40X     
 
        Fig 17: PCM images showing the morphology of NLC Loaded Base Cream 
                    
                                         NLC Loaded Base Cream - 40x 
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SCANING ELECTRON MICROSCOPY 
The surface characteristics of prepared NLC were examined by scanning 
electron microscope (SEM). The suspension was first put on clear glass stub, allowed 
to dry in air followed by coating with gold using Polaren E 5100 sputter coater and 
observed under microscope at different magnification.       
 
 
                   Fig 19:  SEM Images of prepared NLC 
Scanning electron micrographs of NLC are shown in the above Figures. The 
shape of the NLC was spherical and the size of the NLC was found within the 
nanometer range. Moreover, the micrograph also revealed the agglomeration of 
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nanoparticles which might be due to the lipid nature of the carrier and the drying 
process during sample preparation prior to SEM analysis. 
ATOMIC FORCE MICROSCOPY (AFM) 
 
 
                 Fig 20: 2D image and 3D image of AFM analyzed particle 
Atomic Force Microscopy (AFM) study results indicate that the formulation has 
spherical Shape  
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TEXTURE ANALYSIS 
Spreadability: 
Spreadability is the ease of which a product can be spread on skin. It is 
commonly a desired characteristic of ointments, gels, creams and waxes. It is related 
to the firmness of a product and more often than not the ease of spreading is 
associated with a loss in firmness. A good gel takes less time to spread and will have 
high spreadability. During the test the male cone approaches, penetrates and moves 
into the gel sample for a distance of 25mm from its start point. As the probe 
penetrates across the gel the force increases until a point of maximum penetration 
depth. This force value can be taken as the firmness at this specified depth. A firmer 
sample shows a correspondingly larger area that represents the total amount of force 
required to perform the shearing process. The probe then proceeds to withdraw from 
the sample. The maximum negative peak indicates the stickiness of the sample and 
the maximum negative area is taken as the work of adhesion. A stickier sample will 
require a greater force to remove the probe, yielding a larger negative area. Figure 
represents a typical spredability graph of THC Cream. The firmness value obtained 
for THC Cream (209.334g) with force of application is (178.340g.sec). Similarly the 
stickiness value for THC loaded cream is (280.100g). 
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                      Fig 21: Spreadability plot for THC loaded Cream 
Bloom Strength: 
Bloom strength is a measure of the ability of a colloidal dispersion to develop and 
retain a gel form. It is the force, expressed in grams, necessary to depress by 4 mm the 
surface of a gel with a standard 0.5" diameter cylinder probe. During the test when a 
trigger force of 10 g is attained, the probe proceeds to penetrate the cream to a depth 
of 4 mm. During this penetration the force drops at the point where the cream breaks. 
After this the resulting forces are due to continuing penetration up to the required 
depth. The maximum positive force (i.e. the rupture point of the gel) is taken as an 
indication of rupture strength. The distance that the gel penetrates before this break 
occurs gives an indication of the gel's elasticity, i.e. a short distance of penetration 
before break indicates a brittle gel whereas a large distance of penetration before 
rupture indicates a more elastic gel.  A typical bloom strength evaluation plot of THC 
loaded cream is shown in figure . The rupture strength value of THC loaded cream is 
8.552g. 
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                          Fig 22: Bloom Strength plot for THC Loaded Cream 
 
Extrudability Of Cream: 
The consistency of the cream was analysed by extruding it using an HDP/FE 
forward extrusion cell fitted to a Texture Analyser (Stable Micro Systems, 
Godalming, UK). This cell measures the compression force required for a piston to 
extrude a product through a standard size outlet in the base of the container. The 
sample container can accommodate base discs with outlet diameters of 3, 5, 7 or 10 
mm. The selection of the base disc depends on the consistency of the sample. The 
compression-extrusion test consists of applying force on a cream until it flows 
through an outlet that may be in the form of an annulus (hole) present in the disc at 
the bottom of the test cell. The tightly fitted plunger acts almost like a piston 
compresses the sample and causes forward flow of the cream through the annulus of 
the disc. The cream is compressed until the structure of the cream is disrupted and 
starts extruding through the outlet. The pattern of forces involved in such a test is 
complex. Usually the maximum force required to accomplish extrusion is measured 
and used as an index of texture quality.  
The result in figure indicates that from 1 to 2 the sample is deformed and 
compressed to pack more and more tightly into the diminishing space available under 
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the descending plunger; at this point there is little rupture of the sample. At 
approximately the point 2 the sample is packed solid and liquid may be expressed 
from it filling the interstices. At point 2 or soon afterwards the pack is solid except for 
small amounts of entrapped air, and the force increases steeply from 2 pressing out 
more liquid or air in the process. After the point 2 the sample begins to rupture and 
flow through the annulus (extrusion hole), and this process continues to a point when 
the compressing plunger is reversed in direction and the force falls to zero. Point after 
2 gives the force necessary to begin the process of extrusion, and the plateau shows 
the force needed to continue extrusion. It represents the increasing force being applied 
to an almost incompressible mixture of solids and liquid. The shape and magnitude of 
the compression-extrusion curve is influenced by the elasticity, viscoelasticity, 
viscosity, and rupture behaviour of the material; sample size, deformation rate, sample 
temperature, type of test cell; sample test size; and homogeneity of the sample. 
Preliminary tests showed that reproducible results of compression forces could be 
obtained using base discs with an outlet diameter of 3 mm. Lower amount of NLC in 
the cream gave very thick cream. The firmness of the cream in the study was 
346.788g. 
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                         Fig 23: Extrudability of THC Loaded Cream 
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In Vitro Drug Release: 
 Table 10: In vitro Drug Release Study 
S.No Time (hrs) Cumulative % Drug 
Release 
1. 2hr 0.5 
2. 4hr 2.5 
3. 6hr 10.5 
4. 8hr 15 
5. 24hr 45 
6. 48hr 80 
 
 
 Fig 24: In vitro permeation study across pig ear skin
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The in vitro release studies were carried up to 48 hours for the formulations and 80% of drug 
was penetrated through pig ear skin at 48hrs.  
Stability studies 
Stability studies of the formulations THC loaded cream was carried out for 3 months 
according to the ICH guidelines. The result showed that there were no significant changes in 
the cream. 
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SUMMARY AND CONCLUSION 
In general lipid based formulations face stability problems over a longer period of 
time due to microbial contamination which can often change the physical and 
chemical properties of the drugs and excipients. In the current study, an attempt was 
made to enhance the stability of THC loaded lipid based formulations for 
nutricosmeceutical purpose using a natural preservation system. THC loaded 
nanostructured lipid carriers were prepared to serve as a carrier to enhance the 
bioavailability of THC for nutraceutical purpose and lipid based cream loaded with 
NLCs of THC were prepared to serve as a carrier for the delivery of THC for 
cosmetic purpose. 
Initially, essential oils like cinnamon oil, peppermint oil, eucalyptus oil, lavender oil, 
clove oil, lemon grass oil, castor oil, neem oil and their mixtures were evaluated for 
antimicrobial activity. The results indicated a better antimicrobial property for 
cinnamon oil. Hence, THC loaded nanostructured lipid carriers and the corresponding 
creams were prepared using cinnamon oil as liquid oil carrier. THC loaded NLC were 
prepared from stearic acid, cinnamon oil and tween 80 by hot homogenization 
technique using ultra probe sonicator. The spherical shaped nanostructure lipid 
particles with a particle size of 245 nm showed a sustained release pattern across pig 
ear skin for around 48 hours.  These THC loaded nanostructure lipid particles were 
loaded in a lipid based cream (prepared from cetostearyl alcohol, cetyl alcohol, 
myristic acid, palmitic acid and tween 80). Evaluation of the texture properties of the 
lipid cream loaded with THC NLCs showed good firmness and stickiness. THC NLCs 
and lipid based cream loaded with THC NLCs showed good stability during the initial 
3 months without any microbial contamination. Long term stability studies are in 
progress to evaluate the stability of the lipid based formulations for a period of 1 year.  
Lipid based nutricosmeceuticals prepared using cinnamon oil as a liquid oil can be a 
good promising natural preservative against microbial contamination and can possibly 
enhance the stability of several other lipid based nutricosmeceuticals loaded with 
different types of drugs.  
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